Tibet Rhodiola Pharmaceutical Holding Co.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000ZW7
CNY
42.77
4.99 (13.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
438.57
938.60
712.11
631.27
560.75
910.48
697.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
438.57
938.60
712.11
631.27
560.75
910.48
697.31
Raw Material Cost
41.81
60.27
45.84
60.85
49.73
41.80
45.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.06
1.99
0.00
0.08
3.96
2.85
2.41
Selling and Distribution Expenses
248.18
535.63
406.47
385.48
324.24
539.77
413.71
Other Expenses
0.73
1.01
0.38
1.01
0.08
0.38
-0.05
Total Expenditure (Excl Depreciation)
299.33
607.97
456.16
456.47
378.70
588.21
460.76
Operating Profit (PBDIT) excl Other Income
139.2
330.6
256
174.8
182
322.29999999999995
236.6
Other Income
42.31
27.40
54.92
119.11
15.80
41.36
116.18
Operating Profit (PBDIT)
177.54
361.10
322.25
306.10
209.90
365.08
371.20
Interest
2.06
1.99
0.00
0.08
3.96
2.85
2.41
Exceptional Items
0.40
0.60
-1.42
-14.95
0.34
-2.24
-2.13
Gross Profit (PBDT)
396.76
878.33
666.27
570.42
511.01
868.68
652.22
Depreciation
0.00
18.44
18.44
18.61
18.61
18.47
18.47
Profit Before Tax
175.89
341.27
302.39
272.46
187.66
349.25
348.19
Tax
18.02
35.13
31.40
7.33
17.89
37.59
32.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
154.45
298.04
269.28
259.42
168.73
310.22
312.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
154.45
298.04
269.28
259.42
168.73
310.22
312.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.66
2.50
0.97
2.51
0.33
0.62
2.32
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
155.12
300.54
270.25
261.93
169.06
310.84
315.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,551.44
4,161.11
4,101.03
3,917.82
3,629.96
3,791.72
3,659.32
Earnings per share (EPS)
0.48
0.92
0.84
0.8
0.52
0.96
0.97
Diluted Earnings per share
0.48
0.92
0.84
0.8
0.52
0.96
0.97
Operating Profit Margin (Excl OI)
30.84%
33.59%
34.95%
26.67%
31.3%
33.53%
33.92%
Gross Profit Margin
40.11%
38.32%
45.05%
46.11%
36.79%
40.39%
52.58%
PAT Margin
35.22%
31.75%
37.81%
41.1%
30.09%
34.07%
44.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -53.27% vs 31.81% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -48.39% vs 11.21% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -59.48% vs 24.84% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 5.00% vs 0.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Tibet Rhodiola Pharmaceutical Holding Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
438.57
0
438.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
438.57
0
438.57
Raw Material Cost
41.81
0
41.81
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.06
0
2.06
Selling and Distribution Expenses
248.18
0
248.18
Other Expenses
0.73
0.00
0.73
Total Expenditure (Excl Depreciation)
299.33
0
299.33
Operating Profit (PBDIT) excl Other Income
139.23
0.00
139.23
Other Income
42.31
0
42.31
Operating Profit (PBDIT)
177.54
0
177.54
Interest
2.06
0
2.06
Exceptional Items
0.40
0
0.40
Gross Profit (PBDT)
396.76
0
396.76
Depreciation
0.00
0
0.00
Profit Before Tax
175.89
0
175.89
Tax
18.02
0
18.02
Provisions and contingencies
0
0
0.00
Profit After Tax
154.45
0
154.45
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
154.45
0
154.45
Share in Profit of Associates
0
0
0.00
Minority Interest
0.66
0
0.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
155.12
0
155.12
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,551.44
0
3,551.44
Earnings per share (EPS)
0.48
0
0.48
Diluted Earnings per share
0.48
0
0.48
Operating Profit Margin (Excl OI)
30.84%
0%
0.00
30.84%
Gross Profit Margin
40.11%
0%
0.00
40.11%
PAT Margin
35.22%
0%
0.00
35.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 43.86 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -53.27% vs 31.81% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -21.78% vs 2.35% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.51 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -48.39% vs 11.21% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -8.28% vs -35.87% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.52 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -59.48% vs 24.84% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -30.35% vs 11.94% in Sep 2024

Quarterly - Interest
Interest 0.21 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.00% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -47.50% vs -2.44% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.84%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024